← FDA DRUG APPROVALS

FDA NDA · NDA020404

TRETINOIN

Sponsor: MYLAN PHARMS INC

APPLICATION
NDA020404
TYPE
NDA
ORIGINAL APPROVAL
1997-01-14
LATEST ACTION
2002-01-22
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

AVITAPrescription
TRETINOIN 0.025% · CREAM · TOPICAL

Approval history

2002-01-22Manufacturing (CMC) · Supplement 5 · standardAP
2001-04-30Manufacturing (CMC) · Supplement 4 · standardAP
2000-03-31Manufacturing (CMC) · Supplement 3 · standardAP
1999-12-15Manufacturing (CMC) · Supplement 2 · standardAP
1997-01-14Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →